Tag Archives: ALNY

Alnylam Pharmaceuticals Inc. (ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment....More>>>

Alnylam Pharmaceuticals Inc. (ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment....More>>>

News about ALNY

Opus Point Partners Management, LLC Buys Bioverativ Inc, ACADIA Pharmaceuticals Inc, United Therapeu
From:www.gurufocus.com
New York, NY, based Investment company Opus Point Partners Management, LLC buys Bioverativ Inc, ACADIA Pharmaceuticals Inc, United Therapeutics Corp, Ultragenyx Pharmaceutical Inc, Alexion Pharmaceuticals Inc, Neurocrine Biosciences Inc, Grifols SA, ...Read More>>>

Dow, S&P 500 finish at records as Fed announces October start to ‘great unwind’
From:www.marketwatch.com
U.S. stock benchmarks ended a volatile session mostly in the green, with the Dow industrials and the S&P 500 carving out fresh all-time highs, as the Federal Reserve announced that, for the first time in nine years, it would start reducing the si...Read More>>>

Mid-Afternoon Market Update: Crude Oil Up Over 2%; Alnylam Pharma Shares Climb After Positive Phase
From:www.benzinga.com
Toward the end of trading Wednesday, the Dow traded down 0.19 percent to 22,328.28 while the NASDAQ declined 0.66 percent to 6,418.93. The S&P also fell, dropping 0.36 percent to 2,497.76. Leading and Lagging Sectors Wednesday afternoon, the ene...Read More>>>

Stocks Cool as Yellen Unleashes ‘Quantitative Tightening’
From:investorplace.com
U.S. equities bounced around the unchanged line on Wednesday in volatile trading after the Federal Reserve, as expected, announced it would begin winding down its bloated $4.4 trillion balance sheet in October. This “quantitative tightening&rdq...Read More>>>

Geopolitical Analyst: Russia's Local Elections Show Cracks In Putin's Power
From:www.benzinga.com
Related RSX Trump Forced To Sign Sanctions Bill Against Russia; Reports Say President And Putin May Have Loopholes The Worst Performing Stock Market Among G20 Countries? Russia Related ERUS Is Ru...Read More>>>